The human body uses 50 hormones to regulate different systems and bodily functions such as growth, metabolism and temperature regulation. There are also a number of hormones that help regulate the development and release of the female reproductive cells, or egg.

Hormonal imbalance is an incorrect quantity of one or more hormones in the bloodstream. The timing of the hormone(s) release, interactions with other hormones and ability to respond through cell receptors are also important for hormonal balance. An irregular balance of the hormones associated with reproductive health in one or both partners can make conception and pregnancy difficult. Hormonal imbalances are the leading cause of infertility in women, but are often treatable with lifestyle changes and medications.

Often times, hormonal imbalance is not diagnosed until an individual experiences infertility. Women may experience one or more of the following symptoms are as: Absent or irregular periods, Spotting between periods, Heavy or painful periods, Increased hair growth on the face, neck, chest, and back, Unexplained weight gain, Constipation and diarrhea.

Hormonal imbalances in men and women can be determined through simple blood or urine analysis. Fertility hormone testing looks at the presence of a variety of hormones central to reproduction to determine whether one or more hormones is depleted or in excess

Treatments for hormonal imbalance may include medications to restore normal thyroid function, normalize hormone levels, induce ovulation or trigger a fully mature egg. Lifestyle modifications, such as weight loss or diet changes can also normalize hormone levels and improve the chances of pregnancy.

Some impact Factors:-

• Increase in unhealthy lifestyle like eating fast food and sleeping fewer causes more and more hormonal infertility.
• Increasing radiation and UV rays direct contact with human bodies
• Increase in uses of hormones like prolactin which is one of the main reasons for hormonal infertility.
• High cost of treatment and social taboos in societies.
• New product development and innovation. Research and development is the most important factor in pharmaceutical industry. SO, stiff market competitions among the market leaders.

What does this Report Provide?

This report provides a detailed understanding of the global Hormonal Infertility demand from a qualitative and quantitative perspective with a forecast next 10 years. The report also provides dynamic indicators with potential impact in the market during the forecast period and in-depth analysis of the leading companies operating in the global Hormonal Infertility market. The major market drivers, challenges and opportunities for the Hormonal Infertility are also covered in the market. This report also includes the market share of the leading Hormonal Infertility producers along with their production capacities and growth strategies adopted by them. 

Market Segmentation:-

By Gland: 

• Hypothalamus (Ovaries, Pituitary Gland, Others)
• Hormones (Luteinizing Hormone, Kisspeptin, Others)

By Diseases:-

• Polycystic Ovary Syndrome
• Pituitary Tumors, Diabetes
• Menopause
• Cushing’s Syndrome
• STDs
• Polyps & Fibroids
• Others

By Diagnosis:-

• Ultrasound
• Blood & Urine Tests
• Hysterosalpingography
• Ovarian Reserve Testing, Others)
• Treatment Medication, Surgery
• Assisted Reproductive Technology
• Others Medication, Surgery
• Assisted Reproductive Technology
• Others

By Region:-

North America Hormonal infertility market:

• North America, by Country
• US
• Canada
• Mexico
• North America, by Gland
• North America, by Diseases
• North America, by Diagnosis

Europe Hormonal infertility market:

• Europe, by Country
• Germany
• Russia
• UK
• France
• Italy
• Spain
• The Netherlands
• Rest of Europe 
• Europe, by Gland
• Europe, by Diseases
• Europe, by Diagnosis

Asia Pacific Hormonal infertility market:

• Asia Pacific, by Country
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Rest of Asia Pacific 
• Asia Pacific, by Gland
• Asia Pacific, by Diseases
• Asia Pacific, by Diagnosis

Middle East & Africa Hormonal infertility market:

• Middle East & Africa, by Country 
• UAE
• Saudi Arabia
• Qatar
• South Africa
• Rest of Middle East & Africa
• Middle East & Africa, by Gland
• Middle East & Africa, by Diseases
• Middle East & Africa, by Diagnosis

South America Hormonal infertility market:

• South America, by Country 
• Brazil
• Argentina
• Colombia
• Rest of South America
• South America, by Gland
• South America, by Diseases
• South America, by Diagnosis

Key Players: Par Pharmaceutical, Allergan, Arbor Pharmaceuticals, TerSera Therapeutics LLC., Novartis AG, Teva Pharmaceuticals Industries Ltd., Sun Pharmaceuticals Industries Ltd., AbbVie Inc., and EMD Serono, Inc.

Objectives of this report:-

• To estimate market size for hormonal infertility market on regional and global basis.
• To identify major segments in hormonal infertility market and evaluate their market shares and demand.
• To provide a competitive scenario for the hormonal infertility market with major developments observed by key companies in the historic years.
• To evaluate key factors governing the dynamics of hormonal infertility market with their potential gravity during the forecast period.

Reasons to Buy This Report:-

• Provides niche insights for decision about every possible segment helping in strategic decision making process.
• Market size estimation of the hormonal infertility market on a regional and global basis.
• A unique research design for market size estimation and forecast.
• Identification of major companies operating in the market with related developments
• Exhaustive scope to cover all the possible segments helping every stakeholder in the Hormonal infertility market

Customization:-

This study is customized to meet your specific requirements:

• By Segment
• By Sub-segment
• By Region/Country

For more information, contact: [email protected]